εw@ΆΖΡ |
2016-2018 |
Zou Chencheng@i2018N9mΫφCΉj |
‘_Ά\ |
|
2019 |
Chengcheng Zou,* Hayato Murakoshi,* Nozomi Kuse, Tomohiro Akahoshi, Takayuki Chikata, Hiroyuki Gatanaga, Shinichi Oka, Tomas Hanke, and Masafumi Takiguchi (*Equal contribution), Effective suppression of HIV-1 replication by CTLs specific for Pol epitopes in conserved mosaic vaccine immunogens, J. Virol. In press |
2018 |
Hayato Murakoshi,* Chengcheng Zou,* Nozomi Kuse, Tomohiro Akahoshi, Takayuki Chikata, Hiroyuki Gatanaga, Shinichi Oka, Tomas Hanke, and Masafumi Takiguchi (*Equal contribution), CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication, Retrovirology 15:46, 2018 |
‘wο\ |
|
2018 |
Chengcheng Zou, Hayato Murakoshi, Nozomi Kuse, Hiroyuki Gatanaga, Shinichi Oka, Tomas Hanke, and Masafumi Takiguchi, Control of HIV-1 by CD8+ T cells specific for Gag epitopes in conserved-region mosaic vaccine, Keystone Symposia: Progress and Pathways Toward an Effective HIV Vaccine (J6) (Banff, Canada), January 28 - February 1, 2018, National Institute of Allergy and Infectious Diseases (NIAID) Scholarship |
2017 | Chengcheng Zou, Hayato Murakoshi, and Masafumi Takiguchi, Conserved epitope-specific CTLs controlling HIV-1 replication, ζ46ρϊ{ΖuwοwpWοiεδj, 2017N1212-14ϊ |
Chengcheng Zou, Hayato Murakoshi, Nozomi Kuse, Hiroyuki Gatanaga, Shinichi Oka, Tomas Hanke, and Masafumi Takiguchi, Control of HIV-1 by CD8+ T cells recognizing Gag conserved region, 18th Kumamoto AIDS Seminar (Kumamoto, Japan), October 30 - November 1, 2017 | |
2016 |
Chengcheng Zou, Zhansong Lin, Hiroyuki Gatanaga, Shinichi Oka, and Masafumi Takiguchi, No association of HLA-E allelic variants with clinical parameters in chronically HIV-1 infected Japanese population, 2nd Kumamoto IRCMS International Symposium and 17th Kumamoto AIDS Seminar (Kumamoto, Japan), October 31 - November 2, 2016 |
@ΆΖΡTOPΦίι |